HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clark DuMontier Selected Research

Bortezomib (Velcade)

10/2023More intensive therapy as more effective treatment for frail patients with multiple myeloma [corrected].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Clark DuMontier Research Topics

Disease

4Frailty
08/2023 - 06/2021
3Neoplasms (Cancer)
01/2021 - 01/2019
2Multiple Myeloma
10/2023 - 06/2021
2Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 01/2021
1Cognitive Dysfunction
01/2020
1Death (Near-Death Experience)
01/2020
1Heart Failure
01/2020
1Chronic Obstructive Pulmonary Disease (COPD)
01/2020
1Breast Neoplasms (Breast Cancer)
01/2018

Drug/Important Bio-Agent (IBA)

1Dexamethasone (Maxidex)FDA LinkGeneric
10/2023
1Bortezomib (Velcade)FDA Link
10/2023
1Lenalidomide (CC 5013)FDA Link
10/2023
1Complement System Proteins (Complement)IBA
08/2023

Therapy/Procedure

3Therapeutics
10/2023 - 01/2018
2Polypharmacy
01/2022 - 01/2022
2Activities of Daily Living (ADL)
01/2020 - 01/2019
1Aftercare (After-Treatment)
01/2021
1Home Nursing (Nursing, Home)
01/2020
1Drug Therapy (Chemotherapy)
01/2018